Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20858838rdf:typepubmed:Citationlld:pubmed
pubmed-article:20858838lifeskim:mentionsumls-concept:C0007258lld:lifeskim
pubmed-article:20858838lifeskim:mentionsumls-concept:C0235394lld:lifeskim
pubmed-article:20858838lifeskim:mentionsumls-concept:C0001721lld:lifeskim
pubmed-article:20858838lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:20858838lifeskim:mentionsumls-concept:C1420140lld:lifeskim
pubmed-article:20858838pubmed:issue19lld:pubmed
pubmed-article:20858838pubmed:dateCreated2010-10-4lld:pubmed
pubmed-article:20858838pubmed:abstractTextCarnitine is an essential cofactor for mitochondrial fatty acid oxidation that is actively reabsorbed by the luminal transporter Octn2 (Slc22a5). Because the nephrotoxic agent cisplatin causes urinary loss of carnitine in humans, we hypothesized that cisplatin may affect Octn2 function.lld:pubmed
pubmed-article:20858838pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:languageenglld:pubmed
pubmed-article:20858838pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:citationSubsetIMlld:pubmed
pubmed-article:20858838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20858838pubmed:statusMEDLINElld:pubmed
pubmed-article:20858838pubmed:monthOctlld:pubmed
pubmed-article:20858838pubmed:issn1078-0432lld:pubmed
pubmed-article:20858838pubmed:authorpubmed-author:SparreboomAle...lld:pubmed
pubmed-article:20858838pubmed:authorpubmed-author:LoosWalter...lld:pubmed
pubmed-article:20858838pubmed:authorpubmed-author:ZuoZhiliZlld:pubmed
pubmed-article:20858838pubmed:authorpubmed-author:ChenZhaoyuanZlld:pubmed
pubmed-article:20858838pubmed:authorpubmed-author:LancasterCynt...lld:pubmed
pubmed-article:20858838pubmed:authorpubmed-author:HuChaoxinClld:pubmed
pubmed-article:20858838pubmed:authorpubmed-author:FrankeRyan...lld:pubmed
pubmed-article:20858838pubmed:authorpubmed-author:FilipskiKelly...lld:pubmed
pubmed-article:20858838pubmed:authorpubmed-author:OrwickShelley...lld:pubmed
pubmed-article:20858838pubmed:copyrightInfo©2010 AACR.lld:pubmed
pubmed-article:20858838pubmed:issnTypePrintlld:pubmed
pubmed-article:20858838pubmed:day1lld:pubmed
pubmed-article:20858838pubmed:volume16lld:pubmed
pubmed-article:20858838pubmed:ownerNLMlld:pubmed
pubmed-article:20858838pubmed:authorsCompleteYlld:pubmed
pubmed-article:20858838pubmed:pagination4789-99lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:meshHeadingpubmed-meshheading:20858838...lld:pubmed
pubmed-article:20858838pubmed:year2010lld:pubmed
pubmed-article:20858838pubmed:articleTitleCisplatin-induced downregulation of OCTN2 affects carnitine wasting.lld:pubmed
pubmed-article:20858838pubmed:affiliationDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.lld:pubmed
pubmed-article:20858838pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20858838pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:20858838pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed